Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
NCT01663662
The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
Phase: Phase 4
Role: Collaborator
Start: Aug 31, 2012
Completion: Nov 30, 2013